Autolus Therapeutics PLC (AUTL) — 10-Q Filings

10-Q Filings (5)

• Autolus Narrows Q3 Loss Amid AUCATZYL Launch, Cash Drains — Nov 12, 2025 Risk: high
  Autolus Therapeutics plc reported a net loss of $79.1 million for the three months ended September 30, 2025, a slight improvement from the $82.1 million net los
• Autolus Therapeutics Q1 2025 10-Q Filed — May 8, 2025 Risk: low
  Autolus Therapeutics plc filed its 10-Q for the period ending March 31, 2025. The company, focused on biological products, reported financial data for the first
• Autolus Therapeutics Q3 2024 Update — Nov 12, 2024 Risk: medium
  Autolus Therapeutics plc filed its 10-Q for the period ending September 30, 2024. The company reported operating expenses of £104.7 million for the nine months
• Autolus Therapeutics plc Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Autolus Therapeutics plc filed its 10-Q for the period ending June 30, 2024. The company reported its financial results for the second quarter and first half of
• Autolus Therapeutics Files Q1 2024 10-Q — May 17, 2024 Risk: medium
  Autolus Therapeutics plc filed a 10-Q for the period ending March 31, 2024. The company reported its financial results and operational highlights. Key financial

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX